EXO70B1 is a subunit of the exocyst complex that mediates early tethering during exocytosis in plants. This protein plays a central role in the plant immune response through several mechanisms:
It functions in vesicle trafficking required for early immune signaling
It contributes to resistance against various pathogens including bacteria, fungi, and oomycetes
EXO70B1 mutants display pathogen-specific immune phenotypes, with both compromised and enhanced resistance depending on the pathogen
It associates with the SNARE complex protein SNAP33, which is involved in focal secretion of defense-related proteins
Research shows that exo70B1 mutants display lesion-mimic cell death and reduced responsiveness to pathogen-associated molecular patterns (PAMPs), creating complex immunity-related phenotypes .
EXO70B1 has distinct functions compared to other exocyst subunits:
Unlike its closest homolog EXO70B2, exo70B1 mutants show enhanced resistance to biotrophic pathogens like Hyaloperonospora arabidopsidis (Hpa)
EXO70B1 specifically interacts with TIR-NBS2 (TN2), an atypical NLR-like disease resistance protein lacking the LRR domain
It is recruited to the plasma membrane by the immunity-related RIN4 protein, and this localization can be manipulated by Pseudomonas syringae effectors
These unique interactions suggest EXO70B1 may be specifically targeted by pathogens as a virulence strategy and monitored by plant immune receptors .
Based on published research, an optimized co-immunoprecipitation protocol includes:
Extract proteins from fresh plant tissue using a buffer containing 50mM HEPES (pH 7.5), 150mM NaCl, 1mM EDTA, 1% Triton X-100, and protease inhibitors
Clear lysate by centrifugation (14,000g, 10 minutes)
Pre-clear lysate with Protein A/G beads
Incubate with anti-EXO70B1 antibody or anti-tag antibody overnight at 4°C
Add Protein A/G magnetic beads and incubate for 3 hours
Wash beads thoroughly (4-5 times)
Elute bound proteins and analyze by immunoblotting
Research has successfully used anti-GFP magnetic beads to immunoprecipitate EXO70B1 and detected it with anti-HA antibody, demonstrating the effectiveness of this approach .
Critical considerations include:
Maintaining native protein conformation during extraction
Including appropriate negative controls (non-specific IgG)
Using mild detergents to preserve protein-protein interactions
Performing reciprocal co-IPs to confirm interactions
The complex and seemingly contradictory phenotypes in exo70B1 mutants require careful analysis:
To reconcile these phenotypes, researchers should:
Consider pathogen lifestyle (biotroph vs. hemibiotroph)
Analyze the timing of defense responses (early PAMP-triggered vs. later effector-triggered)
Distinguish between different types of cell death (programmed cell death vs. necrosis)
Create double mutants with defense pathway components (e.g., npr1, sid2)
Research indicates that exo70B1 mutants have reduced PAMP responsiveness while simultaneously exhibiting enhanced cell death (lesion-mimic phenotype) . This creates a complex balance where the net effect on resistance depends on which mechanism is more important for defense against a particular pathogen.
Based on published research, effective approaches include:
Pathogen Challenge Assays:
Bacterial infection with Pseudomonas syringae at 5×10^5 CFU/mL, measure bacterial growth at 3 days post-infection
Hpa infection followed by trypan blue staining to detect cell death response
Documentation of disease symptoms and quantification of pathogen growth
Gene Expression Analysis:
RT-qPCR to measure defense marker genes (PR1, PAD4, SID2, NPR1)
Compare expression patterns between wild-type and exo70B1 mutants before and after infection
PAMP Response Assays:
Measure early PAMP-triggered responses (ROS burst, MAPK activation)
Compare with appropriate controls (pub22/pub23/pub24 triple mutant shows enhanced PAMP responses, npr1 shows compromised SA signaling)
Research has shown these approaches effectively characterize the complex immunity-related phenotypes in exo70B1 mutants .
Studies have revealed critical insights into the EXO70B1-TN2 relationship:
Loss-of-function of EXO70B1 leads to activation of TN2, an NLR-like disease resistance protein
TN2 physically associates with EXO70B1 in yeast and in planta
TN2 is required for the enhanced disease resistance and cell death phenotypes in exo70B1 mutants
TN2 is an atypical NLR that lacks the LRR domain common in typical NLR receptors
This relationship suggests a model where:
EXO70B1 may be targeted by pathogen effectors to manipulate plant secretion
TN2 monitors EXO70B1 integrity as part of an immune receptor complex
This represents a novel "guard" mechanism where an atypical NLR monitors a component of the secretory pathway
This discovery connects vesicle trafficking components to NLR-mediated immunity and expands our understanding of immune surveillance mechanisms .
Research has indicated connections between EXO70B1 and autophagy/cell death pathways:
Evidence suggests EXO70B1 may be involved in autophagy-related transport to the vacuole
Autophagy plays both negative and positive roles in immunity and cell death
exo70B1 mutants display lesion-mimic cell death phenotypes that are SA-dependent
This cell death is more pronounced in older plants (>6 weeks)
The interplay between these processes raises important research questions:
Is EXO70B1's role in autophagy directly related to its immune functions?
How does EXO70B1 regulate the balance between different types of cell death?
What is the mechanistic relationship between vesicle trafficking, autophagy, and cell death?
Understanding these relationships could provide insights into how plants coordinate different cellular processes during immune responses.
When conducting localization studies with EXO70B1 antibodies, the following controls are essential:
Antibody Specificity Controls:
Perform immunostaining with pre-immune serum
Use exo70B1 null mutant tissues as negative control
Include peptide competition assays to confirm specificity
Subcellular Marker Controls:
Co-stain with established markers for plasma membrane (H⁺-ATPase)
Use markers for vesicle trafficking (Rab GTPases)
Include other exocyst subunits as reference
Treatment Controls:
Compare localization patterns before and after pathogen infection
Analyze localization after PAMP treatment (e.g., flg22)
Include pharmaceutical treatments affecting secretion
Research has shown that EXO70B1 localization changes upon immune activation, and it can be recruited to the plasma membrane by RIN4 . These dynamic changes must be carefully controlled and documented.
To distinguish direct from indirect effects, researchers should employ:
Genetic Approaches:
Generate specific domain mutants of EXO70B1 that affect only certain functions
Create double mutants with components of different defense pathways
Use inducible expression systems to study immediate vs. delayed effects
Biochemical Approaches:
Conduct in vitro reconstitution experiments with purified components
Perform temporal studies measuring signaling events at multiple timepoints
Use proximity labeling techniques to identify proteins in close contact with EXO70B1 during immune activation
Systems Biology Approaches:
Perform transcriptomics, proteomics, and metabolomics analyses on exo70B1 mutants
Develop network models integrating multiple datasets
Validate predictions using targeted experiments
These approaches can help determine whether EXO70B1 directly participates in immune signaling or if its effects are mediated through its role in secretion and vesicle trafficking.